Current therapies for the treatment of malignancies are associated wit
h significant limitations to the hematopoietic system since chemothera
py and radiation therapy do not discriminate between normal and malign
ant cells. Since bone marrow depression occurs at low to midlethal dos
es of irradiation, approaches to improving the therapeutic index of tr
eatment must include measures to enhance the sensitivity of the tumor
relative to normal hematopoietic tissue or, by reducing toxicity to no
rmal hematopoietic tissues leaving tumor resistance unchanged. Radiopr
otective agents have been proposed to unravel the fundamental processe
s by which radiation itself damages hematopoietic tissue. In radiother
apy, the importance of these agents is derived from their potential us
e as selective protectors against radiation damage to normal hematopoi
etic tissue such that higher doses of radiation can be delivered to tu
mors to achieve a therapeutic advantage. A variety of agents have been
and are being evaluated as possible protectants. These include aminot
hiols, synthetic polysaccharides, vitamins and cytokines. This review
attempts to summarize the role both chemical and biological response m
odifiers play as hematopoietic radioprotectors. In addition, possible
mechanisms of protection of hematopoietic stem cells from irradiation
are discussed.